Market Place
Sourcing Support
All News #Library
Rare Diseases
SELLAS Receives EMA Orphan Drug Designation For SLS009
06 Aug 2024 //
GLOBENEWSWIRE
SELLAS` SLS009 Receives FDA Rare Pediatric Disease Designation For AML
16 Jul 2024 //
GLOBENEWSWIRE
Sellas Receive EMA Orphan Drug Designation For SLS009 For Acute Myeloid Leukemia
08 Jul 2024 //
GLOBENEWSWIRE
SELLAS Gets FDA Rare Pediatric Disease Designation For SLS009 In Pediatric ALL
24 Jun 2024 //
GLOBENEWSWIRE
SELLAS Receives FDA Orphan Drug Designation for SLS009
21 Dec 2023 //
GLOBENEWSWIRE
SELLAS Receives FDA Orphan Drug Designation for SLS009
10 Oct 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.